tm logo
RAZVIAM
Dead/Abandoned
PETITION TO REVIVE-RECEIVED

received

on 11 Jun 2024

Last Applicant/ Owned by

Clonshaugh Business & Technology Park

Dublin 17

IE

D17E400

Serial Number

97773225 filed on 30th Jan 2023

Registration Number

N/A

Correspondent Address

MAIL CODE: AND-250C

IRVINE, CA 92612

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RAZVIAM

pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97773225

Mark Type

No Service/Collective Mark

Attorney Docket Number

No RAZVIAM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
11th Jun 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
05th Dec 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10th Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10th Oct 2023PUBLISHED FOR OPPOSITION
20th Sep 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01st Sep 2023APPROVED FOR PUB - PRINCIPAL REGISTER
31st Aug 2023ASSIGNED TO EXAMINER
16th Feb 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02th Feb 2023NEW APPLICATION ENTERED